investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of mTORC2 in GBM - development of a novel therapeutic mTOR kinase inhibitor

Paul S Mischel

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Paul S Mischel

Ludwig Institute for Cancer Research

Heidelberg, Australia | Uppsala, Sweden

Related projects

Perinatal, Familial, and Neighborhood Risk Factors for Childhood Cancer

Brain, nervous system

Pediatric oncology or childhood cancer

Genaro R. Villa

A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep

Brain, nervous system

Frank Furnari

Genotypic Interactions in Brain Cancer Heterogeneity

Brain, nervous system

Michael Gottesman

Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells

Ovary Melanoma of skin Liver and intrahepatic bile ducts Leukaemia Brain, nervous system

Sadhan Majumder

Implications of a novel glioblastoma classification defined by miR-21-Sox2 status

Brain, nervous system

Lisa Schum Kahalley

Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor

Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer

Dipak Panigrahy

Control of Cancer and Metastasis by Endothelial-Derived Epoxyeicosatrienoic Acids

Breast Brain, nervous system

Suzanne J Baker

Cooperating Pathways in Gliomagenesis

Brain, nervous system